1 - 10 of 21

Beverly L. Davidson, PhD

Photo of Beverly L. Davidson, PhD

Dr. Davidson works to understand the molecular basis of childhood onset neurodegenerative diseases and the development of gene and small molecule therapies for treatment. She also focuses on how noncoding RNAs participate in neural development and neurodegenerative disease processes, and how they can be harnessed for therapies.


Diva D. De León-Crutchlow, MD, MSCE

Diva D. De León-Crutchlow

Dr. De Leon-Crutchlow’s translational research program focuses on examining the pathophysiology of disorders of insulin regulation, identifying novel therapeutic targets, and developing new therapies for these conditions. The program approach includes patient-oriented research and bench research employing mouse models and primary islet cultures.


Thomas De Raedt, PhD

Thomas De Raedt

Dr. De Raedt researches pediatric high grade glioma development and aims to understand the involvement of crucial pathways. He investigates pathway interaction, and explores ways to develop therapies through analyzing human tumors, performing cellular studies, and developing accurate mouse models. This allows Dr. De Raedt and his team to perform novel pre-clinical studies that can lead to clinical trials.


Matthew A. Deardorff , MD, PhD

Photo of Matthew A. Deardorff

Dr. Deardorff’s work integrates patient information with genomics and cell biology to diagnosis and understand rare genetic disease.  His research focuses on disorders caused by dysregulation of chromatin or altered translational regulation, specifically, Cornelia de Lange, Coffin-Siris, Skraban-Deardorff and KBG syndromes.


Andrew Degnan, MD, MPhil

Andrew Degnan, MD, MPhil

Dr. Degnan's research and clinical training has focused on the development and application of imaging approaches to advance patient care through accurate diagnosis and improved prognostication.


Sara B. DeMauro, MD, MSCE

Sara B. DeMauro, MD, MSCE

Dr. DeMauro has special expertise in rigorous assessment of early childhood outcomes of high-risk neonates. Her research focuses on improving outcomes of children with bronchopulmonary dysplasia and school-age assessment of functional outcomes in preterm-born children.